AAAAAA
Results:
1-12
|
Results: 12
Authors:
Mangia, A
Minerva, N
Annese, M
Leandro, G
Villani, MR
Santoro, R
Carretta, V
Bacca, D
Giangaspero, A
Bisceglia, M
Ventrella, F
Dell'Erba, G
Andriulli, A
Citation: A. Mangia et al., A randomized trial of amantadine and interferon versus interferon alone asinitial treatment for chronic hepatitis C, HEPATOLOGY, 33(4), 2001, pp. 989-993
Authors:
Perri, F
Villani, MR
Quitadamo, M
Annese, V
Niro, GA
Andriulli, A
Citation: F. Perri et al., Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadrupletherapy?, ALIM PHARM, 15(7), 2001, pp. 1017-1022
Authors:
Perri, F
Villani, MR
Festa, V
Quitadamo, M
Andriulli, A
Citation: F. Perri et al., Predictors of failure of Helicobacter pylori eradication with the standard'Maastricht triple therapy', ALIM PHARM, 15(7), 2001, pp. 1023-1029
Authors:
Mangia, A
Villani, MR
Minerva, N
Leandro, G
Bacca, D
Cela, M
Carretta, V
Attino, V
Ventrella, F
Giangaspero, A
Andriulli, A
Citation: A. Mangia et al., Efficacy of 5 MU of interferon in combination with ribavirin for naive patients with chronic hepatitis C virus: a randomized controlled trial, J HEPATOL, 34(3), 2001, pp. 441-446
Authors:
Pompili, M
Rapaccini, GL
Covino, M
Pignataro, G
Caturelli, E
Siena, DA
Villani, MR
Cedrone, A
Gasbarrini, G
Citation: M. Pompili et al., Prognostic factors for survival in patients with compensated cirrhosis andsmall hepatocellular carcinoma after percutaneous ethanol injection therapy, CANCER, 92(1), 2001, pp. 126-135
Authors:
Perri, F
Festa, V
Clemente, R
Villani, MR
Quitadamo, M
Caruso, N
Li Bergoli, M
Andriulli, A
Citation: F. Perri et al., Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies, AM J GASTRO, 96(1), 2001, pp. 58-62
Authors:
Cedrone, A
Covino, M
Caturelli, E
Pompili, M
Lorenzelli, G
Villani, MR
Valle, D
Sperandeo, M
Rapaccini, GL
Gasbarrini, G
Citation: A. Cedrone et al., Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: Does different viral etiology influence AFPlevels in HCC? A study in 350 western patients, HEP-GASTRO, 47(36), 2000, pp. 1654-1658
Authors:
Caturelli, E
Siena, DA
Fusilli, S
Villani, MR
Schiavone, G
Nardella, M
Balzano, S
Florio, F
Citation: E. Caturelli et al., Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: Evaluation of damage to nontumorous liver tissue-long-term prospective study, RADIOLOGY, 215(1), 2000, pp. 123-128
Authors:
Andriulli, A
Leandro, G
Niro, G
Mangia, A
Festa, V
Gambassi, G
Villani, MR
Facciorusso, D
Conoscitore, P
Spirito, F
De Maio, G
Citation: A. Andriulli et al., Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis, GASTROIN EN, 51(1), 2000, pp. 1-7
Authors:
Mangia, A
Gentile, R
Cascavilla, I
Margaglione, M
Villani, MR
Stella, F
Modola, G
Agostiano, V
Gaudiano, C
Andriulli, A
Citation: A. Mangia et al., HLA class II favors clearance of HCV infection and progression of the chronic liver damage, J HEPATOL, 30(6), 1999, pp. 984-989
Authors:
Annese, V
Caruso, N
Bisceglia, M
Lombardi, G
Clemente, R
Modola, G
Tardio, B
Villani, MR
Andriulli, A
Citation: V. Annese et al., Fatal ulcerative panenteritis following colectomy in a patient with ulcerative colitis, DIG DIS SCI, 44(6), 1999, pp. 1189-1195
Authors:
Mangia, A
Schiavone, G
Lezzi, G
Marmo, R
Bruno, F
Villani, MR
Cascavilla, I
Fantasia, L
Andriulli, A
Citation: A. Mangia et al., HCV and diabetes mellitus: Evidence for a negative association, AM J GASTRO, 93(12), 1998, pp. 2363-2367
Risultati:
1-12
|